CHINDEX INTERNATIONAL, INC. ANNOUNCES OPENING OF UNITED FAMILY DOWTOWN CLINIC FACILITY IS SECOND AFFILIATED SATELLITE UNIQUE HOSPITAL NETWORK EXPANDING IN BOTH BEIJING AND SHANGHAI

BETHESDA, MARYLAND - June 23, 2005 - Chindex International, Inc. (NASDAQ: CHDX), an independent American provider of Western healthcare products and medical services in the People's Republic of China, today announced the opening of its United Family Downtown Clinic in Beijing.

The outpatient facility is the second such satellite clinic affiliated with the Company's Beijing United Family Hospital . It is located in the St. Regis Hotel in the heart of the diplomatic district. The clinic will offer a variety of outpatient services including family medicine, dental, immigration physicals and mental health counseling.

Roberta Lipson, Chindex CEO and Chairman of the Board of United Family Hospitals commented on the opening: "With the opening of our United Family Downtown Clinic our premier healthcare services are now more widely available to Beijing 's growing expatriate community. The clinic, located in the heart of the diplomatic district, provides easy access to United Family health services to all the families that live and work in the downtown area. Coming just a few months after the opening our second hospital facility, Shanghai United Family Hospital , this is the next step in the expansion of our United Family Hospital network."

Chindex began its Healthcare Services business in China in 1997 with the opening of China 's first foreign owned and operated for profit hospital in Beijing . Beijing United Family Hospital has been successfully serving the needs of the international residents of Beijing, as well as a growing Chinese patient population who are willing and able to pay for the premium services provided by the hospital. The Company's hospitals in Beijing and Shanghai both offer a broad range of in-patient and ambulatory services which are supplemented by two off-site satellite clinics in Beijing , and one in Shanghai , which help to increase the geographical area served by the hospitals.

Chindex is an American company operating in several healthcare sectors of the Chinese marketplace, including Hong Kong . It provides representative and distribution services to a number of major multinational companies including Siemens AG (ultrasound systems) and Guidant (interventional cardiology products including stents, balloon catheters and guide wires). Its distribution channels to the retail pharmacy industry in China have been developed through a relationship with a major multinational cosmetics manufacturer. It also provides healthcare services through the operations of its private hospitals in China . With twenty-four years of experience, over 1,000 employees, and operations in the United States , China and Hong Kong , the

Company's strategy is to expand its cross-cultural reach by providing leading edge technologies, quality products and services to Greater China's professional communities. Further company information may be found at the Company's websites, www.chindex.com and www.unitedfamilyhospitals.com.

Some of the information in this release may contain statements regarding future expectations, plans, prospects for performance of the Company that constitute forward-looking statements for purposes of the safe harbor provisions of The Private Securities Litigation Reform Act of 1995. The Company cannot guarantee future results, levels of activity, performance or achievements. The numbers discussed in this release also involve risks and uncertainties. The following factors, among others, could cause actual results to differ materially from those described by such statements: our ability to manage our growth and maintain adequate controls, our ability to obtain additional financing, the loss of services of key personnel, general market conditions including inflation or foreign currency fluctuations, our dependence on relationships with suppliers, the timing of our revenues and fluctuations in financial performance, the availability to our customers of third-party financings, product liability claims and product recalls, competition, hiring and retaining qualified sales and service personnel, management of inventory, relations with foreign trade corporations, dependence on sub-distributors and dealers, completion and opening of healthcare facilities, attracting and retaining qualified physicians and other hospital personnel, regulatory compliance, the cost of malpractice, our dependence on our information systems, the economic policies of the Chinese government, the newness and undeveloped nature of the Chinese legal system, the regulation of the conversion of Chinese currency, future epidemics in China such as SARS, the control over our operation by insiders, continuity of relationships and variability of financial margins with existing suppliers, our liquidity and availability of capital resources to meet cash requirements, including capital expenditures and those other factors contained in the section titled "Risk Factors" as set forth on page 6 of the Company's Registration Statement on Form S-3 (File No. 333-123975) declared effective by the Securities and Exchange Commission on April 20, 2005, as well as other documents that may be filed by the Company from time to time with the Securities and Exchange Commission. The forward-looking statements and numbers contained herein represent the judgment of the Company, as of the date of this press release, and the Company disclaims any intent or obligation to update such forward-looking statements to reflect any change in the Company's expectations with regard thereto or any change in events, conditions, circumstances on which such statements are based.

# # # #